Alkem Laboratories Announces 52nd AGM and Annual Report for FY 2025-2026

Alkem Laboratories Ltd has announced its 52nd Annual General Meeting (AGM) scheduled for Thursday, August 27, 2026, at 11:00 a.m. The meeting will be conducted via Video Conferencing (VC)/ Other Audio-Visual Means (OAVM). Along with the AGM notice, the company has also released its Annual Report for the financial year 2025-2026. The report, themed 'The Next Shape of Growth', details the company's evolution into a future-ready healthcare organization, focusing on diversification into MedTech, strengthening innovation-led growth in biosimilars, and preparing for future healthcare opportunities like GLP-1 therapies. The report is available on the company's website.